| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HLA-DRA |
P01903
|
major histocompatibility complex, class II, DR alpha
|
Immune response
|
0.52 |
0.581 |
0.769 |
| PRRC2A |
P48634
|
proline rich coiled-coil 2A
|
Enzyme
|
1.00 |
0.656 |
0.654 |
| HBS1L |
Q9Y450
|
HBS1 like translational GTPase
|
Enzyme
|
1.9E-07 |
0.705 |
0.462 |
| CCHCR1 |
Q8TD31
|
coiled-coil alpha-helical rod protein 1
|
|
1.0E-16 |
0.505 |
0.808 |
| MICB |
Q29980
|
MHC class I polypeptide-related sequence B
|
|
4.1E-05 |
0.576 |
0.731 |
| BAG6 |
P46379
|
BAG cochaperone 6
|
Enzyme modulator
|
1.00 |
0.674 |
0.615 |
| TH2LCRR |
|
T helper type 2 locus control region associated RNA
|
|
|
0.751 |
0.385 |
| PBX2 |
P40425
|
PBX homeobox 2
|
Transcription factor
|
1.00 |
0.686 |
0.462 |
| IL13 |
P35225
|
interleukin 13
|
|
1.4E-02 |
0.386 |
0.846 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| COL11A2 |
P13942
|
collagen type XI alpha 2 chain
|
|
0.70 |
0.435 |
0.846 |
| LY6G6D |
O95868
|
lymphocyte antigen 6 family member G6D
|
|
3.3E-02 |
0.805 |
0.385 |
| MPIG6B |
O95866
|
megakaryocyte and platelet inhibitory receptor G6b
|
|
1.1E-06 |
0.695 |
0.500 |
| LY6G6C |
O95867
|
lymphocyte antigen 6 family member G6C
|
|
4.9E-04 |
0.821 |
0.385 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
| VWA7 |
Q9Y334
|
von Willebrand factor A domain containing 7
|
|
2.3E-11 |
0.839 |
0.308 |
| GATA3 |
P23771
|
GATA binding protein 3
|
|
0.90 |
0.415 |
0.846 |
| CLSTN2 |
Q9H4D0
|
calsyntenin 2
|
Calcium-binding protein
|
3.5E-06 |
0.716 |
0.423 |
| HLA-DPA3 |
|
major histocompatibility complex, class II, DP alpha 3 (pseudogene)
|
|
|
0.805 |
0.308 |
| GATA3-AS1 |
|
GATA3 antisense RNA 1
|
|
|
0.931 |
0.192 |
| TCF3 |
P15923
|
transcription factor 3
|
Transcription factor
|
2.6E-02 |
0.476 |
0.846 |